|Last Update: 05/17/13 - 4:00 PM EDT|
|YTD Performance: -3.17%|
|Previous Close: $33.30|
|52 Week Range: $29.59 - $38.80|
|Oustanding Shares: 320,140,393|
|Market Cap: 10,660,675,087|
|Qtr (06/13)||Qtr (09/13)||FY (12/13)||FY (12/14)|
|Number of Analysts||16||15||18||17|
|Growth Rate (Year over Year)||-38.25%||-27.89%||-16.76%||24.54%|
ALTR estimates were reduced given weaker-than-expected guidance given a slower rebound in industrial growth and VMI hub conversion, said UBS. Price target goes to $34.50.
ALTR was downgraded to Neutral, said UBS. Altera's growth and upside potential over the next several years are likely to be limited by Xilinx's increased competitiveness.
ALTR was downgraded from Outperform to Market Perform, William Blair said. Margins may have peaked as the company is facing product cycle headwinds.
ALTR was downgraded from Buy to Neutral, Lazard Capital Markets said. Company faces macro growth headwinds.
Shares of ALTR now seen reaching $35, Jefferies said. Estimates also lowered on mid- quarter update. Hold rating.
ALTR estimates were cut through 2013, BMO Capital said. Company is seeing lower sales. Outperform rating and new $38 price target.
Shares of ALTR downgraded to Hold from Buy, Jefferies said. $38 price target. Fairly valued, limited catalysts.
We need some good macro news to clear an upward path.
Is it a coincidence that potential QE3 news sparked a market rally just minutes before the close?